Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5359-5370

  Li, Guoping ^a,b,c   Fox III, John ^a   Liu, Zhigang ^c   Liu, Jun ^d   Gao, George F ^d   Jin, Yang ^e   Gao, Hongwei ^e   Wu, Min ^a,f  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c Shenzhen University Health Science Center   (China)

^d INSTITUTE OF MICROBIOLOGY   (China)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; HOUSE DUST ALLERGEN; MUCIN 5AC; NEUTRALIZING ANTIBODY; PROTEIN KINASE LYN; SMAD2 PROTEIN; SMAD3 PROTEIN; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT INFLAMMATION;

EID: 84888331319     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301596     Document Type: Article

References (61)

1. Makino, S., and H. Sagara. 2010. Evolution of asthma concept and effect of current asthma management guidelines. Allergy Asthma Immunol. Res. 2: 172-176.
2. Girodet, P. O., A. Ozier, I. Bara, J. M. Tunon de Lara, R. Marthan, and P. Berger. 2011. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol. Ther. 130: 325-337.
3. Halwani, R., S. Al-Muhsen, and Q. Hamid. 2010. Airway remodeling in asthma. Curr. Opin. Pharmacol. 10: 236-245.
4. Gregory, L. G., S. A. Mathie, S. A. Walker, S. Pegorier, C. P. Jones, and C. M. Lloyd. 2010. Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am. J. Respir. Crit. Care Med. 182: 143-154.
5. Johnson, J. R., A. Roos, T. Berg, M. Nord, and J. Fuxe. 2011. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PLoS ONE 6: e16175.
6. Hackett, T. L. 2012. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr. Opin. Allergy Clin. Immunol. 12: 53-59.
7. Boxall, C., S. T. Holgate, and D. E. Davies. 2006. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur. Respir. J. 27: 208-229.
8. Bottoms, S. E., J. E. Howell, A. K. Reinhardt, I. C. Evans, and R. J. McAnulty. 2010. Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS ONE 5: e9674.
9. Halwani, R., S. Al-Muhsen, H. Al-Jahdali, and Q. Hamid. 2011. Role of transforming growth factor-β in airway remodeling in asthma. Am. J. Respir. Cell Mol. Biol. 44: 127-133.
10. Makinde, T., R. F. Murphy, and D. K. Agrawal. 2007. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol. Cell Biol. 85: 348-356.
11. Yamasaki, M., H. R. Kang, R. J. Homer, S. P. Chapoval, S. J. Cho, B. J. Lee, J. A. Elias, and C. G. Lee. 2008. P21 regulates TGF-beta1-induced pulmonary responses via a TNF-alpha-signaling pathway. Am. J. Respir. Cell Mol. Biol. 38: 346-353.
12. Wen, F. Q., X. Liu, T. Kobayashi, S. Abe, Q. Fang, T. Kohyama, R. Ertl, Y. Terasaki, L. Manouilova, and S. I. Rennard. 2004. Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads. Am. J. Respir. Cell Mol. Biol. 30: 816-822.
13. Wójcik, K., P. Koczurkiewicz, M. Michalik, and M. Sanak. 2012. Transforming growth factor-β1-induced expression of connective tissue growth factor is enhanced in bronchial fibroblasts derived from asthmatic patients. Pol. Arch. Med. Wewn. 122: 326-332.
14. Torrego, A., M. Hew, T. Oates, M. Sukkar, and K. Fan Chung. 2007. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 62: 307-313.
15. Balzar, S., H. W. Chu, P. Silkoff, M. Cundall, J. B. Trudeau, M. Strand, and S. Wenzel. 2005. Increased TGF-beta2 in severe asthma with eosinophilia. J. Allergy Clin. Immunol. 115: 110-117.
16. Kariyawasam, H. H., S. Pegorier, J. Barkans, G. Xanthou, M. Aizen, S. Ying, A. B. Kay, C. M. Lloyd, and D. S. Robinson. 2009. Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J. Allergy Clin. Immunol. 124: 454-462.
17. Fattouh, R., N. G. Midence, K. Arias, J. R. Johnson, T. D. Walker, S. Goncharova, K. P. Souza, R. C. Gregory, Jr., S. Lonning, J. Gauldie, and M. Jordana. 2008. Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am. J. Respir. Crit. Care Med. 177: 593-603.
18. Wong, W. S., and K. P. Leong. 2004. Tyrosine kinase inhibitors: a new approach for asthma. Biochim. Biophys. Acta 1697: 53-69.
19. Kannan, S., H. Huang, D. Seeger, A. Audet, Y. Chen, C. Huang, H. Gao, S. Li, and M. Wu. 2009. Alveolar epithelial type II cells activate alveolar macrophages and mitigate P. aeruginosa infection. PLoS ONE 4: e4891.
20. Kannan, S., A. Audet, H. Huang, L. J. Chen, and M. Wu. 2008. Cholesterol-rich membrane rafts and Lyn are involved in phagocytosis during Pseudomonas aeruginosa infection. J. Immunol. 180: 2396-2408.
21. Dai, S., M. V. Rajaram, H. M. Curry, R. Leander, and L. S. Schlesinger. 2013. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog. 9: e1003114.
22. Leander, R., S. Dai, L. S. Schlesinger, and A. Friedman. 2012. A mathematical model of CR3/TLR2 crosstalk in the context of Francisella tularensis infection. PLOS Comput. Biol. 8: e1002757.
23. Adachi, T., S. Stafford, S. Sur, and R. Alam. 1999. A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic inflammation. J. Immunol. 163: 939-946.
24. Beavitt, S. J., K. W. Harder, J. M. Kemp, J. Jones, C. Quilici, F. Casagranda, E. Lam, D. Turner, S. Brennan, P. D. Sly, et al. 2005. Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity. J. Immunol. 175: 1867-1875.
25. Tsantikos, E., C. Quilici, K. W. Harder, B. Wang, H. J. Zhu, G. P. Anderson, D. M. Tarlinton, and M. L. Hibbs. 2009. Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice. J. Immunol. 183: 2484-2494.
26. Pazdrak, K., L. Justement, and R. Alam. 1995. Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J. Immunol. 155: 4454-4458.
27. Smith, P. G., H. Tanaka, and A. Chantry. 2012. A novel co-operative mechanism linking TGFβ and Lyn kinase activation to imatinib resistance in chronic myeloid leukaemia cells. Oncotarget 3: 518-524.
28. Li, G. P., Z. G. Liu, J. Qiu, P. X. Ran, and N. S. Zhong. 2005. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model. Chin. Med. J. (Engl.) 118: 534-540.
29. Suzaki, Y., K. Hamada, T. Nomi, T. Ito, M. Sho, Y. Kai, Y. Nakajima, and H. Kimura. 2008. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation. Eur. Respir. J. 31: 783-789.
30. Di Valentin, E., C. Crahay, N. Garbacki, B. Hennuy, M. Guéders, A. Noël, J. M. Foidart, J. Grooten, A. Colige, J. Piette, and D. Cataldo. 2009. New asthma biomarkers: lessons from murine models of acute and chronic asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L185-L197.
31. Philippe, B., O. Ibrahim-Granet, M. C. Prévost, M. A. Gougerot-Pocidalo, M. Sanchez Perez, A. Van der Meeren, and J. P. Latgé. 2003. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect. Immun. 71: 3034-3042.
32. Yao, Y., F. Zhang, R. Zhou, M. Li, and D. A. Wang. 2010. Continuous supply of TGFβ3 via adenoviral vector promotes type I collagen and viability of fibroblasts in alginate hydrogel. J. Tissue Eng. Regen. Med. 4: 497-504.
33. Wang, I. J., C. Y. Wu, and F. R. Hu. 2007. Effect of proinflammatory cytokines on the human MUC5AC promoter activity in vitro and in vivo. Clin Ophthalmol 1: 71-77.
34. Chung, W. C., S. H. Ryu, H. Sun, D. C. Zeldin, and J. S. Koo. 2009. CREB mediates prostaglandin F2alpha-induced MUC5AC overexpression. J. Immunol. 182: 2349-2356.
35. Goplen, N., M. Z. Karim, Q. Liang, M. M. Gorska, S. Rozario, L. Guo, and R. Alam. 2009. Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma. J. Allergy Clin. Immunol. 123: 925-932, e911.
36. Parmley, R. R., and S. J. Gendler. 1998. Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus. J. Clin. Invest. 102: 1798-1806.
37. Min, L. J., T. X. Cui, Y. Yahata, K. Yamasaki, T. Shiuchi, H. W. Liu, R. Chen, J. M. Li, M. Okumura, T. Jinno, et al. 2004. Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes. Endocrinology 145: 253-260.
38. Mushaben, E. M., G. K. Hershey, M. W. Pauciulo, W. C. Nichols, and T. D. Le Cras. 2012. Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice. PLoS ONE 7: e32468.
39. Perez-G, M., M. Melo, A. D. Keegan, and J. Zamorano. 2002. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J. Immunol. 168: 1428-1434.
40. Tsang, M. L., L. Zhou, B. L. Zheng, J. Wenker, G. Fransen, J. Humphrey, J. M. Smith, M. O'Connor-McCourt, R. Lucas, and J. A. Weatherbee. 1995. Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII). Cytokine 7: 389-397.
41. Heijink, I. H., D. S. Postma, J. A. Noordhoek, M. Broekema, and A. Kapus. 2010. House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 42: 69-79.
42. Shintani, Y., M. Maeda, N. Chaika, K. R. Johnson, and M. J. Wheelock. 2008. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. Am. J. Respir. Cell Mol. Biol. 38: 95-104.
43. Dolhnikoff, M., L. F. da Silva, B. B. de Araujo, H. A. Gomes, S. Fernezlian, A. Mulder, J. H. Lindeman, and T. Mauad. 2009. The outer wall of small airways is a major site of remodeling in fatal asthma. J. Allergy Clin. Immunol. 123: 1090-1097, 1097 e1091.
44. Dekkers, B. G., D. Schaafsma, S. A. Nelemans, J. Zaagsma, and H. Meurs. 2007. Extracellular matrix proteins differentially regulate airway smooth muscle phenotype and function. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1405-L1413.
45. Odaka, M., S. Matsukura, H. Kuga, F. Kokubu, T. Kasama, M. Kurokawa, M. Kawaguchi, K. Ieki, S. Suzuki, S. Watanabe, et al. 2007. Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells. Int. Arch. Allergy Immunol. 143(Suppl 1): 84-88.
46. Blease, K., J. M. Schuh, C. Jakubzick, N. W. Lukacs, S. L. Kunkel, B. H. Joshi, R. K. Puri, M. H. Kaplan, and C. M. Hogaboam. 2002. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am. J. Pathol. 160: 481-490.
47. Quarcoo, D., S. Weixler, D. Groneberg, R. Joachim, B. Ahrens, A. H. Wagner, M. Hecker, and E. Hamelmann. 2004. Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J. Allergy Clin. Immunol. 114: 288-295.
48. Edwards, M. R., N. W. Bartlett, D. Clarke, M. Birrell, M. Belvisi, and S. L. Johnston. 2009. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol. Ther. 121: 1-13.
49. McMillan, S. J., G. Xanthou, and C. M. Lloyd. 2005. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J. Immunol. 174: 5774-5780.
50. Zhu, Y., and P. J. Bertics. 2011. Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils. J. Immunol. 186: 516-526.
51. Krebs, D. L., M. K. Chehal, A. Sio, N. D. Huntington, M. L. Da, P. Ziltener, M. Inglese, N. Kountouri, J. J. Priatel, J. Jones, et al. 2012. Lyn-dependent signaling regulates the innate immune response by controlling dendritic cell activation of NK cells. J. Immunol. 188: 5094-5105.
52. Antoniu, S. A. 2010. Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema. Curr. Opin. Investig. Drugs 11: 1286-1294.
53. Tomkinson, A., J. Tepper, M. Morton, A. Bowden, L. Stevens, P. Harris, D. Lindell, N. Fitch, R. Gundel, and E. B. Getz. 2010. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma. Allergy 65: 69-77.
54. Wenzel, S., D. Wilbraham, R. Fuller, E. B. Getz, and M. Longphre. 2007. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370: 1422-1431.
55. Alcorn, J. F., L. M. Rinaldi, E. F. Jaffe, M. van Loon, J. H. Bates, Y. M. Janssen-Heininger, and C. G. Irvin. 2007. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am. J. Respir. Crit. Care Med. 176: 974-982.
56. Busse, P. J., T. F. Zhang, B. Schofield, S. Kilaru, S. Patil, and X. M. Li. 2009. Decrease in airway mucous gene expression caused by treatment with anti-tumor necrosis factor alpha in a murine model of allergic asthma. Ann. Allergy Asthma Immunol. 103: 295-303.
57. Peters-Golden, M. 2004. The alveolar macrophage: the forgotten cell in asthma. Am. J. Respir. Cell Mol. Biol. 31: 3-7.
58. Burton, P. B., P. Quirke, C. M. Sorensen, S. L. Nehlsen-Cannarella, L. L. Bailey, and D. E. Knight. 1993. Growth factor expression during rat development: a comparison of TGF-beta 3, TGF-alpha, bFGF, PDGF and PDGF-R. Int. J. Exp. Pathol. 74: 87-96.
59. Khalil, N., R. N. O'Connor, K. C. Flanders, and H. Unruh. 1996. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell Mol. Biol. 14: 131-138.
60. Borthwick, L. A., S. M. Parker, K. A. Brougham, G. E. Johnson, M. R. Gorowiec, C.Ward, J. L. Lordan, P. A. Corris, J. A. Kirby, and A. J. Fisher. 2009. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax 64: 770-777.
61. Lewis, C. C., H. W. Chu, J. Y. Westcott, A. Tucker, E. L. Langmack, E. R. Sutherland, and M. Kraft. 2005. Airway fibroblasts exhibit a synthetic phenotype in severe asthma. J. Allergy Clin. Immunol. 115: 534-540.